key: cord-0922696-hdfms9uh authors: Ciuffreda, Laura; Alcoba-Florez, Julia; Lorenzo-Salazar, José M.; Gil-Campesino, Helena; de Artola, Diego García-Martínez; Díez-Gil, Oscar; Rodríguez-Pérez, Héctor; Íñigo-Campos, Antonio; Valenzuela-Fernández, Agustín; González-Montelongo, Rafaela; Flores, Carlos title: Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021 date: 2022-04-22 journal: J Infect DOI: 10.1016/j.jinf.2022.04.030 sha: bbb970c74fb040d94041ccbd6556dedaac807d10 doc_id: 922696 cord_uid: hdfms9uh nan The spreading of SARS-CoV-2 variants of concern (VOCs) have been associated with a surge of COVID-19 cases and the burden of the healthcare systems worldwide (https://www.who.int/en/activities/tracking-SARS-CoV-2-variants). In response, the Reference Centre for the Network of COVID-19 Genomic Surveillance in the Canary Islands (Spain) was established in our laboratories by the regional public health system. We tracked the early emergence of the Alpha variant (Alcoba-Florez et al., 2021) and described the introduction and dynamics of four VOCs in the region from December 2020 to September 2021 (Ciuffreda et al., 2022) . There are major concerns that some VOCs may cause increased disease severity. In this journal, Strålin and colleagues have reported higher rates of hospitalization, severe illness and death among those infected with the Alpha variant (B.1.1.7) compared to non-VOC lineages (Strålin et al., 2022) . Since the Delta (B.1.617.2) variant has been associated with even higher disease severity compared with Alpha (B.1.1.7) (Twohig et al., 2022) , here we aimed to retrospectively assess the association between infection by the two major VOCs circulating in the Canary Islands (Spain) archipelago during the period and 28-day mortality among a cohort of hospitalized patients. The study was conducted at the University Hospital Nuestra Señora de Candelaria (HUNSC) (Santa Cruz de Tenerife, Spain). The institutional review board approved the study (approval CHUNSC_2020_24). As previously described (Ciuffreda et al., 2022) , nasopharyngeal swab samples were collected in the Canary Islands archipelago from December 2020 to September 2021. Of the 8,224 samples analysed throughout the study period, clinical and patient data were available for only a subset of 5,544 samples, out of which 532 samples were collected from hospitalized patients in our centre. To exclude samples from patients who attended the hospital for causes unrelated to COVID-19 or who had a nosocomial SARS-CoV-2 infection, we included in the analysis only those patients who were hospitalized between one and 21 days from symptoms onset. Sample collection, genome sequencing and lineage assignment are briefly described in the supplementary material and further detailed elsewhere (Ciuffreda et al., 2022) . Logistic and Cox proportional hazard regression models adjusting for patient age, sex, days of hospital stay, and personal history of comorbidities were used to assess whether infection by VOCs in hospitalized patients was associated with 28-day hospital mortality. (Ciuffreda et al., 2022) . Despite this, and the higher proportion of vaccination when Delta circulated (50-75% of the population with 1 dose between July and September 2021) than when Alpha circulated (1-35% of the population with 1 dose between January and June 2021) (https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/pbiVacunacion .htm), infection by Delta lineages was associated with higher 28-day hospital mortality compared to that of Alpha irrespective of the model ( Table 1) . Age and male sex were also consistent predictors of higher 28-day hospital mortality. As a limitation, we did not have access to the vaccination status of the patients. This is mainly due to the lack of a centralized system in Spain where patient vaccination status is stored and to the large proportion of the floating or non-resident population in the islands, such as holidaymakers, nomadic workers, or migrants, who lack health status information in the local databases. We aimed to mitigate the bias caused by this by focusing on hospitalized patients, under the idea that their vaccination level was less relevant for disease severity once the patient was hospitalized. Taken together, hospitalized cases with Delta or any of its sub-lineages were associated with higher mortality compared to those with Alpha, adding to the evidence supporting that Delta was more severe than pre-existent SARS-CoV-2 variants (Bager et al., 2021; Freire Rodrigues et al., 2022; Twohig et al., 2022) . The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. This work was supported by Cabildo Insular de Tenerife [grants CGIEU0000219140 and "Apuestas científicas del ITER para colaborar en la lucha contra la COVID-19"]; the agreement with Instituto interpretation of data, in the writing of the manuscript or in the decision to submit the manuscript for publication. Generated consensus sequences were deposited to GISAID. Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid Hospitalisation associated with SARS-CoV-2 delta variant in Denmark Tracing the trajectories of SARS-CoV-2 variants of concern between B.1.617.2 SARS-CoV-2 (Delta) variant is associated with increased risk of hospitalization and death compared with B.1.1.7 SARS-CoV-2 (Alpha) variant", medRxiv Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study We deeply acknowledge the University Hospital Nuestra Señora de Candelaria (HUNSC) and the Instituto Tecnológico y de Energías Renovables (ITER) board of directors for their strong support and assistance in accessing diverse resources used in the study.